Genetic Information
暂无分享,去创建一个
R. Chadwick | A. Thompson | Alison K. Thompson | Ruth F. Chadwick | Alison K. Thompson | Ruth F. Chadwick
[1] A. Cicourel. Method and measurement in sociology , 1965 .
[2] J. Burnham. Madness and Civilization: A History of Insanity in the Age of Reason , 1966 .
[3] Howard S. Becker,et al. Whose Side are we on , 1967 .
[4] C. F. Phillips. Industrial Market Structure and Economic Performance , 1971 .
[5] H. Pearson,et al. Sickle cell testing programs. , 1972, The Journal of pediatrics.
[6] Barry Hindess. The Use of Official Statistics in Sociology , 1973 .
[7] J. Krantz,et al. The birth of the clinic. An archaeology of medical perception , 1975, Medical History.
[8] Jacques Donzelot. The Policing of Families , 1979 .
[9] A. Oakley. Women Confined: Towards a Sociology of Childbirth , 1979 .
[10] P. Rowley,et al. Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: effects on knowledge and mood. , 1979, American journal of human genetics.
[11] V. Bullough,et al. The Civilizing Process: The History of Manners. Volume I , 1979 .
[12] Saul A. Kripke,et al. Naming and Necessity , 1980 .
[13] R. Crawford. Healthism and the Medicalization of Everyday Life , 1980, International journal of health services : planning, administration, evaluation.
[14] M. Walzer. Radical principles : reflections of an unreconstructed democrat , 1980 .
[15] Ronald Dworkin,et al. What is Equality? Part 2: Equality of Resources , 1981 .
[16] D. Melrose. Bitter pills: Medicines and the Third World poor , 1982 .
[17] E. Berscheid,et al. The social psychological implications of facial physical attractiveness. , 1982, Clinics in plastic surgery.
[18] David G. Armstrong. Political anatomy of the body , 1983 .
[19] B. Mcclintock,et al. The significance of responses of the genome to challenge. , 1984, Science.
[20] T. Pinch,et al. The Social Construction of Facts and Artefacts: or How the Sociology of Science and the Sociology of Technology might Benefit Each Other , 1984 .
[21] J. Sorenson,et al. Sex of provider as a variable in effective genetic counseling. , 1984, Social science & medicine.
[22] R. Janko. Forgetfulness in the Golden Tablets of Memory , 1984, The Classical Quarterly.
[23] C. Scriver,et al. A private view of heterozygosity: eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening in Montreal. , 1984, American journal of medical genetics.
[24] Brian W. Hogwood,et al. Policy Analysis For The Real World , 1984 .
[25] G. Modiano,et al. PREVENTION OF THALASSAEMIA MAJOR IN LATIUM (ITALY) , 1985, The Lancet.
[26] D Blumenthal,et al. Industrial support of university research in biotechnology. , 1986, Science.
[27] A. Oakley. The Captured Womb: A History of the Medical Care of Pregnant Women , 1986 .
[28] Simon Blackburn,et al. Spreading the word : groundings in the philosophy of language , 1987 .
[29] B. Merz. Matchmaking scheme solves Tay-Sachs problem. , 1987, JAMA.
[30] D. Gauthier. Morals by Agreement , 1987 .
[31] W. Bijker. The social construction of bakelite: toward a theory of invention , 1987 .
[32] J. Boyle. The Search for an Author: Shakespeare and the Framers , 1988 .
[33] E. Vichinsky,et al. Newborn screening for sickle cell disease: effect on mortality. , 1988, Pediatrics.
[34] Richard Bellamy,et al. The morality of freedom , 1988 .
[35] E. Ebomoyi. Knowledge and attitude towards genetic screening for sickle cell disease. , 1988, Hygie.
[36] R. Rapp,et al. Chromosomes and Communication: The Discourse of Genetic Counseling , 1988, New Approaches to Human Reproduction.
[37] A. Desai. India and the Uruguay Round , 1988 .
[38] William W. Fisher. Reconstructing the Fair Use Doctrine , 1988 .
[39] P. Gärdenfors,et al. Decision, Probability, and Utility : Selected Readings , 1988 .
[40] W. Anderson,et al. Human gene therapy: why draw a line? , 1989, The Journal of medicine and philosophy.
[41] M. Boulton,et al. Community attitudes to cystic fibrosis carrier testing in England: A pilot study , 1989, Prenatal diagnosis.
[42] Richard J. Arneson. Equality and equal opportunity for welfare , 1989 .
[43] R. Westrum. The Social Construction of Technological Systems , 1989 .
[44] R. Drmanac,et al. Sequencing of megabase plus DNA by hybridization: theory of the method. , 1989, Genomics.
[45] M. Pearson. Sociology of race and health , 1989 .
[46] An international survey of attitudes of medical geneticists toward mass screening and access to results. , 1989, Public health reports.
[47] T. Gross,et al. Newborn screening for sickle cell disease. , 1989, Pediatrics.
[48] A. Martínez-Palomo,et al. Biomedical Research in Latin America: Old and New Challenges , 1989, Annals of the New York Academy of Sciences.
[49] M. Söder. Disability as a social construct: the labelling approach revisited , 1989 .
[50] B. Burroughs. Cystic fibrosis miscalculation. , 1989, MCN. The American journal of maternal child nursing.
[51] G. Guyatt,et al. The Developing Human: Clinically Oriented Embryology, 6th edition, Keith L. Moore, T.V.N. Persaud (Eds.). W.B. Saunders, Philadelphia (1998) , 1999 .
[52] P. Burke. Distinction: a social critique of the judgement of taste , 1989 .
[53] M. Ryan. The argument for unlimited procreative liberty: a feminist critique. , 1990, The Hastings Center report.
[54] J. D. Watson. The human genome project: past, present, and future. , 1990, Science.
[55] M. Hayden,et al. Ethical and legal dilemmas arising during predictive testing for adult-onset disease: the experience of Huntington disease. , 1990, American journal of human genetics.
[56] A. Clarke. Genetics, ethics, and audit , 1990, The Lancet.
[57] A. Phoenix. Black women and the maternity services , 1990 .
[58] M. France-Dawson. Sickle cell conditions and health knowledge. , 1990, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[59] G. Annas,et al. Outrageous fortune: selling other people's cells. , 1990, The Hastings Center report.
[60] N. Zohar. Prospects for "genetic therapy" -- can a person benefit from being altered? , 1991, Bioethics.
[61] B. Edelman. EXPERIMENTATION SUR L'HOMME : UNE LOI SACRIFICIELLE , 1991 .
[62] J. Mattéi. The Use of Prenatal Diagnosis for Psychiatric Diseases , 1991 .
[63] R. Elton,et al. What do young people think about screening for cystic fibrosis? , 1991, Journal of medical genetics.
[64] A. Lippman,et al. Prenatal Genetic Testing and Screening: Constructing Needs and Reinforcing Inequities , 2020, American Journal of Law & Medicine.
[65] Marshall A. Leaffer. Protecting United States Intellectual Property Abroad: Toward a New Multilateralism , 1991 .
[66] Peter Jaszi,et al. Toward a Theory of Copyright: The Metamorphoses of “Authorship” , 1991 .
[67] D. Parfit. Equality or Priority , 1991 .
[68] R. Williamson,et al. Attitudes to carrier screening for cystic fibrosis: a survey of health care professionals, relatives of sufferers and other members of the public. , 1991, The British journal of general practice : the journal of the Royal College of General Practitioners.
[69] J. Beckwith,et al. Foreword: The Human Genome Initiative: Genetics’ Lightning Rod , 1991, American Journal of Law & Medicine.
[70] C. Wills,et al. Exons, Introns, And Talking Genes: The Science Behind The Human Genome Project , 1991 .
[71] G. Evers‐Kiebooms,et al. Community knowledge about human genetics. , 1992, Birth defects original article series.
[72] R. Williamson,et al. Psychological and social consequences of community carrier screening programme for cystic fibrosis , 1992, The Lancet.
[73] S. Avineri,et al. Communitarianism and individualism , 1992 .
[74] R. Lewontin,et al. The dream of the human genome: doubts about the Human Genome Project. , 1992, The New York review of books.
[75] Zygmunt Bauman,et al. Survival as a Social Construct , 1992, The Body.
[76] R. G. Adler. Genome research: fulfilling the public's expectations for knowledge and commercialization. , 1992, Science.
[77] R. Veatch. The Ends of Human Life: Medical Ethics in a Liberal Polity , 1992 .
[78] B. Turner,et al. Regulating Bodies: Essays in Medical Sociology , 1992 .
[79] V. Penchaszadeh,et al. Psychosocial aspects of genetic counseling: cross-cultural issues. , 1992, Birth defects original article series.
[80] Sandi Wiggins,et al. The Psychological Consequences of Predictive Testing for Huntington’s Disease , 1992 .
[81] M. Oliver. Changing the Social Relations of Research Production , 1992 .
[82] A. Clarke,et al. Children with genetic diseases: who should pay? , 1992, The Lancet.
[83] Neil Postman,et al. Technopoly: The Surrender of Culture to Technology , 1993 .
[84] R. Pokorski. Use of genetic information by private insurers. Genetic advances: the perspective of an insurance medical director. , 1992, Journal of insurance medicine.
[85] Fersko Rs,et al. Intellectual property issues in a clinical trial: a corporate perspective. , 1992 .
[86] S. Dyson,et al. Thalassaemia: Current community knowledge in Manchester. , 1993 .
[87] E. Lorenzi. The effects of comprehensive guidelines for the care of sickle-cell patients in crisis on the nurses' knowledge base and job satisfaction for care given. , 1993, Journal of advanced nursing.
[88] David G. Armstrong. Public Health Spaces and the Fabrication of Identity , 1993 .
[89] S. Cherensky. A Penny for Their Thoughts: Employee-Inventors, Preinvention Assignment Agreements, Property, and Personhood , 1993 .
[90] E. Haan. Screening for carriers of genetic disease: points to consider , 1993, The Medical journal of Australia.
[91] B. Kay. Democracy and Deliberation: New Directions for Democratic Reform James S. Fishkin New Haven: Yale University Press, 1991, pp. viii, 133 , 1993, Canadian Journal of Political Science.
[92] G. Evers‐Kiebooms,et al. Perception of predictive testing for Huntington's disease by young women: preferring uncertainty to certainty? , 1993, Journal of medical genetics.
[93] M. Douglas,et al. Risk and Rationality: Philosophical Foundations for Populist Reforms . By K. S. Shrader-Frechette. Berkeley: University of California Press, 1991. 312p. $39.95 cloth, $15.95 paper. , 1993, American Political Science Review.
[94] Sheila Jasanoff,et al. Procedural Choices in Regulatory Science , 1993 .
[95] L. Lemkow. Public attitudes to genetic engineering : some European perspectives , 1993 .
[96] J. Burn. Screening for cystic fibrosis in primary care. , 1993, BMJ.
[97] B. Dodet. Commercial prospects for gene therapy--a company survey. , 1993, Trends in biotechnology.
[98] J. Last. Global change: ozone depletion, greenhouse warming, and public health. , 1993, Annual review of public health.
[99] S. Dyson,et al. Thalassaemia: establishing basic awareness. , 1993 .
[100] B. Rothman. The tentative pregnancy: then and now. , 1993, Fetal diagnosis and therapy.
[101] I. Henderson. Risk factors for breast cancer development , 1993, Cancer.
[102] G. Annas,et al. Privacy rules for DNA databanks. Protecting coded 'future diaries'. , 1993, JAMA.
[103] A. Milunsky. Commercialization of clinical genetic laboratory services: in whose best interest? , 1993, Obstetrics and gynecology.
[104] C. Anderson. Genome project goes commercial. , 1993, Science.
[105] K. Midence,et al. Increasing awareness for higher quality care. Measuring knowledge of sickle cell disease in adult patients. , 1994, Professional nurse.
[106] Motulsky Ag. Predictive genetic diagnosis. , 1994 .
[107] I. Kennedy,et al. Medical law: Text with materials , 1994 .
[108] B. Looney. Should genes be patented? The gene patenting controversy: legal, ethical, and policy foundations of an international agreement. , 1994, Law and policy in international business.
[109] A. Zulman. Ethical and legal medical issues. , 1994, Australian family physician.
[110] Isaac Rabino,et al. How European and U.S. Genetic Engineering Scientists View the Impact of Public Attention on Their Field: A Comparison , 1994, Science, technology & human values.
[111] S. P. Fodor,et al. Light-generated oligonucleotide arrays for rapid DNA sequence analysis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[112] D. Pilon,et al. [Familial adenomatous polyposis]. , 1994, L'union medicale du Canada.
[113] W. Ahmad. Reflections on the consanguinity and birth outcome debate. , 1994, Journal of public health medicine.
[114] M. B. Marques. Brazil-US controversy on the impact of patenting in biotechnology: some relevant questions for pharmaceuticals , 1994 .
[115] D. Cates. Commentary on genetic knowledge and self-understanding , 1994 .
[116] T. Marteau,et al. Lack of knowledge in health professionals: a barrier to providing information to patients? , 1994, Quality in health care : QHC.
[117] P. Champagne,et al. L'information médicale sous contrainte. A propos du «scandale du sang contaminé» , 1994 .
[118] Amitai Etzioni,et al. The spirit of community : the reinvention of American society , 1994 .
[119] C. Howard. Ethical issues of molecular genetics in psychiatry , 1994 .
[120] N. Holtzman,et al. Assessing Genetic Risks , 1994 .
[121] David Shapiro. “A Single National Voice for Bioethics”: Reflections from Europe , 1994, Politics and the Life Sciences.
[122] T. Shakespeare. Back to the future? New genetics and disabled people , 1995 .
[123] G. Kolata. Tests to assess risks for cancer raising questions. , 1995, The New York times on the Web.
[124] P. Williams. Should We Prevent Down's Syndrome? , 1995 .
[125] P. Silverman. Commerce and genetic diagnostics. , 1995, The Hastings Center report.
[126] G. Mudur. India. New rules push researchers closer to biotech industry. , 1995, Science.
[127] I. Persson. Genetic therapy, identity and the person-regarding reasons. , 1995, Bioethics.
[128] L. Shanner. The right to procreate: when rights claims have gone wrong. , 1995, McGill law journal. Revue de droit de McGill.
[129] S. Crespi. Biotechnology patenting: the wicked animal must defend itself. , 1995, European intellectual property review.
[130] Carol B. Perez,et al. Principles of Biomedical Ethics, 4th Edition , 1995 .
[131] G. Annas,et al. The Genetic Privacy Act and commentary , 1995 .
[132] M. Hammersley. The politics of social research , 1995 .
[133] A. Buchanan. Equal Opportunity and Genetic Intervention , 1995, Social Philosophy and Policy.
[134] M. Malinowski. Bringing Human Genome-Related Biotechnology to Market: A Matter of Survival , 1995 .
[135] E. Emanuel,et al. Preserving the physician-patient relationship in the era of managed care. , 1995, JAMA.
[136] D. Brock,et al. Heterozygote Screening for Cystic Fibrosis , 1994, European journal of human genetics : EJHG.
[137] L. Bently,et al. The ethics of patenting: towards a transgenic patent system. , 1995, Medical law review.
[138] P. Swinnerton-Dyer. The importance of academic freedom , 1995, Nature.
[139] S. Dyson. Clients-as-researchers: issues in haemoglobinopathy research. , 1995 .
[140] C. Weijer. Our Bodies, Our Science , 1995 .
[141] G. Tangwa. Bioethics: an African perspective. , 1996, Bioethics.
[142] M. Calnan,et al. The 'limits' of medicalization?: modern medicine and the lay populace in 'late' modernity. , 1996, Social science & medicine.
[143] S. Rosenberg,et al. Secrecy in medical research. , 1996, The New England journal of medicine.
[144] N. Wald,et al. Down's syndrome screening in UK , 1996, The Lancet.
[145] R. McNally,et al. Bio-Patenting and Biodiversity : Comparative Advantages in a New Global Order. , 1996 .
[146] P. Drahoš. A philosophy of intellectual property , 1996 .
[147] J. A. Robertson. Genetic selection of offspring characteristics. , 1996, Boston University law review. Boston University. School of Law.
[148] M. Wadman. Panel softens cancer gene test warning , 1996, Nature.
[149] C. Smaje. The Ethnic Patterning of Health: New Directions for Theory and Research , 1996 .
[150] R. Kenen. The at-risk health status and technology: a diagnostic invitation and the 'gift' of knowing. , 1996, Social science & medicine.
[151] J. Boyle. Shamans, Software, and Spleens: Law and the Construction of the Information Society , 1996 .
[152] A. Buchanan. Choosing who will be disabled: genetic intervention and the morality of inclusion. , 1996, Social philosophy & policy.
[153] D. Lockhart,et al. Expression monitoring by hybridization to high-density oligonucleotide arrays , 1996, Nature Biotechnology.
[154] R Ottman,et al. Gene-environment interaction: definitions and study designs. , 1996, Preventive medicine.
[155] W. Welkenhuysen,et al. Jongeren en erfelijkheid. Hun beeldvorming over erfelijke ziekten, erfelijke risico=s en genetische tests , 1996 .
[156] Michael Billig,et al. Accounts of health and illness: Dilemmas and representations , 1996 .
[157] Public understanding of science , 1996, The Lancet.
[158] T. Caulfield,et al. Eugenic Policies in Alberta: From the Systematic to the Systemic , 1996 .
[159] M. Wadman. Drug company 'suppressed' publication of research , 1996, Nature.
[160] R. Bellevue,et al. Pregnancy in Sickle Cell Disease: Experience of the Cooperative Study of Sickle Cell Disease , 1996, Obstetrics and gynecology.
[161] M. Stacey. The troubled helix: The new genetics: a feminist view , 1996 .
[162] J. Wood-Harper,et al. The troubled helix: Ethics of human genome analysis: some virtues and vices , 1996 .
[163] M. Mennuti. A 35-year-old pregnant woman considering maternal serum screening and amniocentesis. , 1996, JAMA.
[164] A False Start? The Impact of Federal Policy on the Genotechnology Industry , 1996 .
[165] J. Merz,et al. Patenting gene sequences , 1996, BMJ.
[166] S. Dyson,et al. Midwives' and senior student midwives' knowledge of haemaglobinopathies in England. , 1996, Midwifery.
[167] E. Emanuel,et al. Physician-drug company conflict of interest. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[168] K. Aoki. (Intellectual) Property and Sovereignty: Notes toward a Cultural Geography of Authorship , 1996 .
[169] A. F. Prouty. Quebec biotechnology: The quiet revolution , 1996, Nature Biotechnology.
[170] Unrealistic optimism and genetic risk , 1996 .
[171] G. Evers‐Kiebooms,et al. Adolescents’ Attitude towards Carrier Testing for Cystic Fibrosis and Its Relative Stability over Time , 1996, European journal of human genetics : EJHG.
[172] K. Dierickx. Ethische reflecties omtrent het tijdstip voor een screening op gendragerschap , 1997 .
[173] I. Persson. Genetic therapy, person-regarding reasons and the determination of identity -- a reply to Robert Elliot. , 1997, Bioethics.
[174] A. Bowcock,et al. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. , 1997, The New England journal of medicine.
[175] E. Thomson,et al. Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II. BRCA1 and BRCA2 , 1997 .
[176] D. Resnik. The Morality of Human Gene Patents , 1997, Kennedy Institute of Ethics journal.
[177] A. Roses,et al. The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective. , 1997, JAMA.
[178] R. J. Blatt,et al. Commercialization of genetic testing services: the FDA, market forces, and biological tarot cards. , 1997, Tulane law review.
[179] B Healy,et al. BRCA genes--bookmaking, fortunetelling, and medical care. , 1997, The New England journal of medicine.
[180] E. Mordini. Brain research and human diversities. , 1997, Annali dell'Istituto superiore di sanita.
[181] M. Düwell. Genetic screening: ethical and philosophical perspectives. Review of Genetic Screening: Ethical and Philosophical Perspectives: Final Report of the Euroscreen Project, submitted by Ruth Chadwick. , 1997, Biomedical ethics.
[182] R. Elliot. Genetic therapy, person-regarding reasons and the determination of identity. , 1997, Bioethics.
[183] R. Ford. The morality of biotech patents: differing legal obligations in Europe? , 1997, European intellectual property review.
[184] B. Sweetman. Between Facts and Norms: Contributions to a Discourse Theory of Law and Democracy , 1997 .
[185] Pines Wl. New challenges for medical product promotion and its regulation. , 1997 .
[186] K M Kuntz,et al. Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. , 1997, The New England journal of medicine.
[187] S. Lehrman. Investment analysts paint rosy prospect for biotech , 1997, Nature.
[188] E. Stein,et al. The ethics of genetic research on sexual orientation. , 1997, The Hastings Center report.
[189] K. Hoshino. Japanese and Western Bioethics , 1997, Philosophy and Medicine.
[190] R. Geneve,et al. The commercialization of biotechnology. , 1997 .
[191] L. L. Dahm. Using the DNA profile as the unique patient identifier in the Community Health Information Network: legal implications. , 1997, The John Marshall journal of computer & information law.
[192] A. Amos,et al. The New Genetics: Professionals' Discursive Boundaries , 1997 .
[193] P. Geschiere,et al. The Modernity of Witchcraft: Politics and the Occult in Postcolonial Africa , 1998 .
[194] M. Ghanei,et al. Pre-marriage prevention of thalassaemia: report of a 100,000 case experience in Isfahan. , 1997, Public health.
[195] A. Edwards. The Perfect Baby: A Pragmatic Approach to Genetics , 1997 .
[196] Ann C. H. Kindfield,et al. The dna mystique: the gene as a cultural icon , 1997 .
[197] L. Gannett. Genes and human self-knowledge: historical and philosophical reflections on modern genetics , 1997 .
[198] C. Kurland. Beating scientists into plowshares. , 1997, Science.
[199] J. Kegley. Genetic Knowledge: Human Values and Responsibility , 1998 .